Legend Biotech Corporation American Depositary Shares Earnings Dividend

Legend Biotech Corporation American Depositary Shares’s revenue jumped 56.42% since last year same period to $305.1Mn in the Q1 2026. On a quarterly growth basis, Legend Biotech Corporation American Depositary Shares has generated -0.42% fall in its revenue since last 3-months.

Legend Biotech Corporation American Depositary Shares’s net profit jumped 46.19% since last year same period to $-54.3Mn in the Q1 2026. On a quarterly growth basis, Legend Biotech Corporation American Depositary Shares has generated -76.21% fall in its net profits since last 3-months.

Legend Biotech Corporation American Depositary Shares’s net profit margin jumped 65.6% since last year same period to -17.8% in the Q1 2026. On a quarterly growth basis, Legend Biotech Corporation American Depositary Shares has generated -76.95% fall in its net profit margins since last 3-months.

Legend Biotech Corporation American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.1 - a 575.68% jump from last quarter’s estimates.

Legend Biotech Corporation American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 0.1.

Legend Biotech Corporation American Depositary Shares’s earning per share (EPS) jumped 72.22% since last year same period to -0.15 in the Q1 2026. This indicates that the Legend Biotech Corporation American Depositary Shares has generated 72.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Legend Biotech Corporation American Depositary Shares’s return on assets (ROA) stands at -0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Legend Biotech Corporation American Depositary Shares’s return on equity (ROE) stands at -0.25.